Dog /
FDA CVM · 2025 release 330 reports on file

Coonhound - Bluetick - FDA Adverse Event Profile

Adverse-event records for Coonhound - Bluetick (Dog) from the FDA Center for Veterinary Medicine.

Verify with FDA CVM →
Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 40 30 20 10 0 2018 2019 2020 2021 2022 2023 2024 2025 Reports filed Death-coded reports
Annual report volume for Coonhound - Bluetick drawn from FDA CVM filings.

Data updated June 2026

The record at a glance

Coonhound - Bluetick's FDA record: #162 most-reported dog breed, 330 total reports, 3.3% death-coded (11 reports).

#162
most-reported dog breed
3.3%
death-coded report share
70
Lack of efficacy (endoparasite) - heartworm - top reaction
4.2 yr
average age at report

Higher volume usually means a more popular breed, not a riskier one, compare against how common the breed is.

Total Reports

330

FDA CVM filings

Deaths Reported

11

of 330 reports

Death Rate

3.3%

death-coded share

Avg Age at Report

4.2 yr

28.3 kg avg weight

Death-Coded Outcome Share

Coonhound - Bluetick death-coded reports 3.3%
Cross-breed median

3.3% of 330 coonhound - bluetick reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Average weight at time of report: 28.3 kg (62.4 lbs)

Top Reported Reactions

Lack of efficacy (endoparasite) - heartworm 70
Vomiting 36
Lack of efficacy (endoparasite) - hookworm 35
Lack of efficacy - NOS 26
Lethargy (see also Central nervous system depression in 'Neurological') 21
Emesis 17
INEFFECTIVE, HEARTWORM LARVAE 14
Other abnormal test result NOS 12

Most Referenced Drugs

Milbemycin Oxime + Spinosad 70
Milbemycin Oxime + Praziquantel 56
Moxidectin 52
Pyrantel Pamoate;Sarolaner 37
Ivermectin + Pyrantel As Pamoate Salt 23
Melarsomine Dihydrochloride 18
Oclacitinib Maleate 15
Trilostane 13

Outcome Breakdown

Ongoing
129 (39.1%)
Outcome Unknown
112 (33.9%)
Recovered/Normal
65 (19.7%)
Recovered with Sequela
13 (3.9%)
Died
6 (1.8%)
Euthanized
5 (1.5%)

Gender Distribution

Male 174 (52.7%)
Female 153 (46.4%)
Unknown 2 (0.6%)
Mixed 1 (0.3%)

Reports by Year

Year Reports Trend
2011 1
2012 14
2013 13
2014 14
2015 19
2016 9
2017 23
2018 23
2019 30
2020 26
2021 34
2022 27
2023 40
2024 39
2025 18

Coonhound - Bluetick Pet Health Insights

Coonhound - Bluetick accounts for 330 FDA adverse event reports, ranking #162 by volume among dog breeds, with 11 reports (3.3%) coded as a death outcome. Mean age at report: 4.2 years, average weight 28.3 kg (62.4 lbs).

Top reported signs: Lack of efficacy (endoparasite) - heartworm (70), Vomiting (36), Lack of efficacy (endoparasite) - hookworm (35). Most-referenced drug: Milbemycin Oxime + Spinosad (70 reports), followed by Milbemycin Oxime + Praziquantel (56) and Moxidectin (52).

Outcome coding on 330 status-recorded reports is dominated by Ongoing (39.1%). Annual submissions ranged 2,011-2,025 across 15 years on file.

Dog Breeds With a Similar Report Volume

Frequently Asked Questions

How many FDA adverse event reports involve Coonhound - Bluetick?
There are 330 adverse event reports involving Coonhound - Bluetick in the FDA database, with 11 reports involving death (3.3% death rate). Coonhound - Bluetick ranks #162 by report volume.
What are the most common adverse reactions reported for Coonhound - Bluetick?
The most commonly reported adverse reactions for Coonhound - Bluetick are Lack of efficacy (endoparasite) - heartworm (70 reports), Vomiting (36 reports), Lack of efficacy (endoparasite) - hookworm (35 reports), Lack of efficacy - NOS (26 reports), Lethargy (see also Central nervous system depression in 'Neurological') (21 reports).
What drugs are most frequently associated with Coonhound - Bluetick adverse events?
The drugs most frequently referenced in Coonhound - Bluetick adverse event reports are Milbemycin Oxime + Spinosad (70 reports), Milbemycin Oxime + Praziquantel (56 reports), Moxidectin (52 reports), Pyrantel Pamoate;Sarolaner (37 reports), Ivermectin + Pyrantel As Pamoate Salt (23 reports).
What is the average age of Coonhound - Bluetick in adverse event reports?
The average age of Coonhound - Bluetick at the time of adverse event reports is 4.2 years, with an average weight of 28.3 kg (62.4 lbs).
Does a high number of adverse event reports mean Coonhound - Bluetick is unhealthy?
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Coonhound - Bluetick safety data come from?
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.